NCT06497647 New Treatment for Nocturnal Enuresis in Children
| NCT ID | NCT06497647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Nocturnal Enuresis in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2024-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2024-03-01 with a primary completion date of 2024-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Eligibility Criteria
Inclusion Criteria: * Age : 6 - 18 years old. * All children diagnosed by Primary monosymptomatic nocturnal enuresis in this age group. Exclusion Criteria: * Secondary nocturnal enuresis (child who has been continent for at least 6 months before the onset of bedwetting ). * congenital anomalies (Posterior urethral valve , ectopic ureter , ectopia vesica ,…) * history of previous lower urinary tract surgery (Multiple hypospadias surgeries ,…, ) * neurogenic bladder (as underactive bladder ).and urge incontinence. * presence of post-void residual urine greater than 20% of functional bladder capacity. * history or evidence of disorders in other organs such as (cardiovascular system disease), liver , psychological problems , evident allergic reaction to both medication.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06497647 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Nocturnal Enuresis in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06497647 currently recruiting?
Yes, NCT06497647 is actively recruiting participants. Contact the research team at loaimohamed519@yahoo.com for enrollment information.
Where is the NCT06497647 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06497647 clinical trial?
NCT06497647 is sponsored by Sohag University. The trial plans to enroll 450 participants.